Norges Bank Invests $619,000 in Privia Health Group, Inc. (NASDAQ:PRVA)

Norges Bank acquired a new position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 31,665 shares of the company's stock, valued at approximately $619,000.

Several other institutional investors and hedge funds also recently made changes to their positions in PRVA. Riverbridge Partners LLC increased its holdings in Privia Health Group by 19.7% in the 4th quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company's stock valued at $113,868,000 after buying an additional 958,418 shares during the period. Loomis Sayles & Co. L P increased its stake in Privia Health Group by 55.0% in the fourth quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company's stock valued at $27,727,000 after acquiring an additional 503,002 shares during the period. JPMorgan Chase & Co. raised its position in Privia Health Group by 111.7% in the fourth quarter. JPMorgan Chase & Co. now owns 398,738 shares of the company's stock worth $7,795,000 after purchasing an additional 210,354 shares in the last quarter. Barclays PLC lifted its stake in Privia Health Group by 240.3% during the third quarter. Barclays PLC now owns 224,018 shares of the company's stock worth $4,079,000 after purchasing an additional 158,188 shares during the period. Finally, Sei Investments Co. boosted its stake in Privia Health Group by 26.2% in the 4th quarter. Sei Investments Co. now owns 573,635 shares of the company's stock valued at $11,215,000 after buying an additional 119,052 shares in the last quarter. Institutional investors own 94.48% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

PRVA has been the subject of a number of research reports. Truist Financial raised their target price on Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a research note on Thursday, April 10th. Canaccord Genuity Group lifted their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a research report on Friday, February 28th. JMP Securities set a $29.00 target price on shares of Privia Health Group in a research report on Friday, February 28th. Robert W. Baird increased their target price on shares of Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a report on Tuesday. Finally, Piper Sandler lifted their price target on shares of Privia Health Group from $25.00 to $40.00 and gave the company an "overweight" rating in a research note on Friday, February 28th. One investment analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, Privia Health Group presently has an average rating of "Buy" and a consensus target price of $27.00.

Privia Health Group Trading Up 0.6 %

Shares of Privia Health Group stock traded up $0.14 during trading on Tuesday, hitting $24.19. 376,770 shares of the stock were exchanged, compared to its average volume of 785,562. The company has a fifty day moving average price of $23.77 and a 200-day moving average price of $21.56. The stock has a market capitalization of $2.93 billion, a price-to-earnings ratio of 241.92, a price-to-earnings-growth ratio of 3.47 and a beta of 0.88. Privia Health Group, Inc. has a 1-year low of $15.92 and a 1-year high of $26.04.

Insider Buying and Selling

In other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of the firm's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the completion of the sale, the chief financial officer now owns 179,676 shares of the company's stock, valued at $4,021,148.88. This trade represents a 3.04 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 14.20% of the stock is currently owned by corporate insiders.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.